Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steffen Albrecht

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Nature Genetics|April 8, 2014
Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytomaAdam M Fontebasso, Simon Papillon-Cavanagh, Jeremy Schwartzentruber, et al.
Nature|January 31, 2012
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastomaJeremy Schwartzentruber, Andrey Korshunov, Xiao-Yang Liu, et al.
Cell|December 1, 2020
Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for GliomagenesisCarol C L Chen, Shriya Deshmukh, Selin Jessa, et al.
The Lancet. Oncology|April 18, 2015
Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysisJonathon Torchia, Daniel Picard, Lucie Lafay-Cousin, et al.
Cancer Cell|October 20, 2012
Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastomaDominik Sturm, Hendrik Witt, Volker Hovestadt, et al.
Nature Genetics|April 11, 2017
Spatial heterogeneity in medulloblastomaA Sorana Morrissy, Florence M G Cavalli, Marc Remke, et al.
Acta Neuropathologica|November 1, 2013
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastomaMarc Remke, Vijay Ramaswamy, John Peacock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2014
Cytogenetic prognostication within medulloblastoma subgroupsDavid J H Shih, Paul A Northcott, Marc Remke, et al.
Cancer Cell|June 14, 2017
Intertumoral Heterogeneity within Medulloblastoma SubgroupsFlorence M G Cavalli, Marc Remke, Ladislav Rampasek, et al.
Cancer Cell|December 14, 2016
Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid TumorsJonathon Torchia, Brian Golbourn, Shengrui Feng, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Nature Genetics|April 8, 2014
Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytomaAdam M Fontebasso, Simon Papillon-Cavanagh, Jeremy Schwartzentruber, et al.
Nature|January 31, 2012
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastomaJeremy Schwartzentruber, Andrey Korshunov, Xiao-Yang Liu, et al.
Cell|December 1, 2020
Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for GliomagenesisCarol C L Chen, Shriya Deshmukh, Selin Jessa, et al.
The Lancet. Oncology|April 18, 2015
Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysisJonathon Torchia, Daniel Picard, Lucie Lafay-Cousin, et al.
Cancer Cell|October 20, 2012
Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastomaDominik Sturm, Hendrik Witt, Volker Hovestadt, et al.
Nature Genetics|April 11, 2017
Spatial heterogeneity in medulloblastomaA Sorana Morrissy, Florence M G Cavalli, Marc Remke, et al.
Acta Neuropathologica|November 1, 2013
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastomaMarc Remke, Vijay Ramaswamy, John Peacock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2014
Cytogenetic prognostication within medulloblastoma subgroupsDavid J H Shih, Paul A Northcott, Marc Remke, et al.
Cancer Cell|June 14, 2017
Intertumoral Heterogeneity within Medulloblastoma SubgroupsFlorence M G Cavalli, Marc Remke, Ladislav Rampasek, et al.
Cancer Cell|December 14, 2016
Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid TumorsJonathon Torchia, Brian Golbourn, Shengrui Feng, et al.
Pageof 11